MedTrace Logo

Rudolph: Nasal Microbiota With Red and Sore Nose

NCT03073837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-08-18

No results posted yet for this study

Summary

This pilot study will utilize the experimental rhinovirus infection model to study changes in skin microbiota in relation to skin erythema and soreness.

Conditions

  • Dermatitis

Interventions

OTHER

Rhinovirus Challenge

Challenge with HRV-16 virus

Sponsors & Collaborators

  • NIZO Food Research

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Kimberly-Clark Corporation

    lead INDUSTRY

Principal Investigators

  • Lutter Rene, PhD · AIDS Malignancy Consortium

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2017-04-18
Completion
2017-08-15

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073837 on ClinicalTrials.gov